The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Proinflammatory IgG Fc structures in patients with severe COVID-19
Open accessPublished version of a preprint
Abstract
Severe acute respiratory syndrome coronavirus 2 infections can cause coronavirus disease 2019 (COVID-19), which manifests with a range of severities from mild illness to life-threatening pneumonia and multi-organ failure. Severe COVID-19 is characterized by an inflammatory signature, including high levels of inflammatory cytokines, alveolar inflammatory infiltrates and vascular microthrombi. Here we show that patients with severe COVID-19 produced a unique serologic signature, including an increased likelihood of IgG1 with afucosylated Fc glycans. This Fc modification on severe acute respiratory syndrome coronavirus 2 IgGs enhanced interactions with the activating Fcγ receptor FcγRIIIa; when incorporated into immune complexes, Fc afucosylation enhanced production of inflammatory cytokines by monocytes, including interleukin-6 and tumor necrosis factor. These results show that disease severity in COVID-19 correlates with the presence of proinflammatory IgG Fc structures, including afucosylated IgG1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“On the other hand, antibodies promoting inflammatory responses may contribute to a cytokine storm resulting in severe disease32,33.”
From Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021) · cites this paper as [32]
In the citing paper
“However, the potential role of IgG with reduced Fc fucosylation and enhanced binding to FcγRIII in the development of severe COVID-19 suggests that the quality of antibodies induced by vaccination may also be important in minimizing the risk of ADE32,33.”
From Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Presumed Asymptomatic Carrier Transmission of COVID-19
Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D., Chen, L., & Wang, M. (2020) · JAMA · doi:10.1001/jama.2020.2565 · Cited by 4,496
Epidemiology of COVID-19 Among Children in China
Dong, Y., Mo, X., Hu, Y., Qi, X., Jiang, F., Jiang, Z., & Tong, S. (2020) · PEDIATRICS · doi:10.1542/peds.2020-0702 · Cited by 4,240
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,960
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martínez-Colón, G. J., McKechnie, J. L., Ivison, G. T., Ranganath, T., Vergara, R., Hollis, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0944-y · Cited by 1,493
Self-citationA highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
Yuan, M., Wu, N. C., Zhu, X., Lee, C.-C. D., So, R. T. Y., Lv, H., Mok, C. K. P., & Wilson, I. A. (2020) · Science · doi:10.1126/science.abb7269 · Cited by 1,429
Hu, Z., Song, C., Xu, C., Jin, G., Chen, Y., Xu, X., Ma, H., Chen, W., Lin, Y., Zheng, Y., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1661-4 · Cited by 1,429
Xu, Y., Li, X., Zhu, B., Liang, H., Fang, C., Gong, Y., Guo, Q., Sun, X., Zhao, D., Shen, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0817-4 · Cited by 1,415
Antibody-dependent enhancement of severe dengue disease in humans
Katzelnick, L. C., Gresh, L., Halloran, M. E., Mercado, J. C., Kuan, G. M., Gordon, A. L., Balmaseda, Á., & Harris, E. (2017) · Science · doi:10.1126/science.aan6836 · Cited by 1,202
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Pallesen, J., Wang, N., Corbett, K. S., Wrapp, D., Kirchdoerfer, R. N., Turner, H. L., Cottrell, C. A., Becker, M. M., Wang, L., Shi, W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707304114 · Cited by 1,073
Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,057
Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
Liu, W., Qi, Z., Chen, J., Xiang, R., Song, H., Shu, S., Chen, L., Liang, L., Zhou, J., You, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2003717 · Cited by 784
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Wan, Y., Shang, J., Sun, S., Tai, W., Chen, J., Geng, Q., He, L., Chen, Y., Wu, J., Shi, Z., et al. (2019) · Journal of Virology · doi:10.1128/jvi.02015-19 · Cited by 673
Stadlbauer, D., Amanat, F., Chromikova, V., Jiang, K., Strohmeier, S., Arunkumar, G. A., Tan, J., Bhavsar, D., Capuano, C., Roubidoux, E. K., et al. (2020) · Current Protocols in Microbiology · doi:10.1002/cpmc.100 · Cited by 635
ter Meulen, J., van den Brink, E. N., Poon, L. L. M., Marissen, W. E., Leung, C. S.-W., Cox, F., Cheung, C. Y., Bakker, A. Q., Bogaards, J. A., van Deventer, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030237 · Cited by 599
Halstead, S. B., Nimmannitya, S., & Cohen, S. N. (1970) · PubMed · Cited by 480
Fc‐Receptors as Regulators of Immunity
Nimmerjahn, F., & Ravetch, J. V. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)96005-8 · Cited by 436
IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
Wang, T. T., Sewatanon, J., Memoli, M. J., Wrammert, J., Bournazos, S., Bhaumik, S. K., Pinsky, B. A., Chokephaibulkit, K., Onlamoon, N., Pattanapanyasat, K., et al. (2017) · Science · doi:10.1126/science.aai8128 · Cited by 371
Self-citationModulating IgG effector function by Fc glycan engineering
Li, T., DiLillo, D. J., Bournazos, S., Giddens, J. P., Ravetch, J. V., & Wang, L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702173114 · Cited by 323
Jaume, M., Yip, M., Cheung, C. Y., Leung, N., Li, P. H., Kien, F., Dutry, I., Callendret, B., Escriou, N., Altmeyer, R. M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00671-11 · Cited by 312
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses
Yang, Z., Werner, H. C., Kong, W., Leung, K., Traggiai, E., Lanzavecchia, A., & Nabel, G. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409065102 · Cited by 250
Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
Yip, M., Leung, N., Cheung, C. Y., Li, P. H., Lee, H. H. Y., Daëron, M., Peiris, M. J. S., Bruzzone, R., & Jaume, M. (2014) · Virology Journal · doi:10.1186/1743-422x-11-82 · Cited by 249
Signaling by Antibodies: Recent Progress
Bournazos, S., Wang, T. T., Dahan, R., Maamary, J., & Ravetch, J. V. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052433 · Cited by 230
Self-citationA prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy
Kapur, R., Kustiawan, I., Vestrheim, A., Koeleman, C. A. M., Visser, R., Einarsdottir, H., Porcelijn, L., Jackson, D., Kumpel, B. M., Deelder, A. M., et al. (2013) · Blood · doi:10.1182/blood-2013-09-527978 · Cited by 228
High-Throughput IgG Fc N-Glycosylation Profiling by Mass Spectrometry of Glycopeptides
Pučić‐Baković, M., Selman, M. H. J., Hoffmann, M., Rudan, I., Campbell, H., Deelder, A. M., Lauc, G., & Wuhrer, M. (2013) · Journal of Proteome Research · doi:10.1021/pr300887z · Cited by 208
Graham, R. R., Juffrie, M., Tan, R., Hayes, C. G., Laksono, I. S., Ma’roef, C. N., Erlin, Sutaryo, S., Porter, K. R., & Halstead, S. B. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1999.61.412 · Cited by 200
Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy
Wang, T. T., Maamary, J., Tan, G. S., Bournazos, S., Davis, C. W., Krammer, F., Schlesinger, S. J., Palese, P., Ahmed, R., & Ravetch, J. V. (2015) · Cell · doi:10.1016/j.cell.2015.06.026 · Cited by 198
Self-citationMemoli, M. J., Czajkowski, L. M., Reed, S., Athota, R., Bristol, T., Proudfoot, K., Fargis, S., Stein, M. K., Dunfee, R. L., Shaw, P. A., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu924 · Cited by 153
Self-citationFcγ receptor pathways during active and passive immunization
Bournazos, S., & Ravetch, J. V. (2015) · Immunological Reviews · doi:10.1111/imr.12343 · Cited by 151
The role and function of Fcγ receptors on myeloid cells
Bournazos, S., Wang, T. T., & Ravetch, J. V. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0045-2016 · Cited by 138
Self-citationChen, G., Wang, Y., Qiu, L., Qin, X., Liu, H., Wang, X., Wang, Y., Song, G., Li, F., Guo, Y., et al. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.02.001 · Cited by 135
Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood
de Haan, N., Reiding, K. R., Driessen, G. J. A., van der Burg, M., & Wuhrer, M. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00038 · Cited by 102
Gonzalez, D. C., Castro, O., Kourí, G., Pérez, J., Martinez, E., Vázquez, S., Rosario, D., Cancio, R., & Guzmán, M. G. (2005) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2004.07.012 · Cited by 90
IgG Fc Glycosylation in Human Immunity
Wang, T. T. (2019) · Current topics in microbiology and immunology · doi:10.1007/82_2019_152 · Cited by 84
Self-citationMaternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants
Thulin, N. K., Brewer, R. C., Sherwood, R., Bournazos, S., Edwards, K., Ramadoss, N. S., Taubenberger, J. K., Memoli, M. J., Gentles, A. J., Jagannathan, P., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107642 · Cited by 66
Self-citationAntibody-Enhanced Infection of Monocytes as the Pathogenetic Mechanism for Severe Dengue Illness
Kliks, S. C. (1990) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1990.6.993 · Cited by 60
Roberts, J. T., & Barb, A. W. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005273 · Cited by 41
PI3K limits TNF‐ α production in CD16‐activated monocytes
Kramer, P. R., Winger, V., & Reuben, J. S. (2009) · European Journal of Immunology · doi:10.1002/eji.200838801 · Cited by 26
Jagannathan, P., Kakuru, A., Okiring, J., Muhindo, M. K., Natureeba, P., Nakalembe, M., Opira, B., Olwoch, P., Nankya, F., Ssewanyana, I., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002606 · Cited by 26
Self-citationThe Role and Function of Fcγ Receptors on Myeloid Cells
Bournazos, S., Wang, T. T., & Ravetch, J. V. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch22 · Cited by 13
Self-citation
Research works printed but not linked: 1
- Bournazos, S., Wang, T. T. & Ravetch, J. V. In Myeloid Cells in Health and Disease: A Synthesis (Ed. Gordon, S.) Ch. 22 (ASM Press, 2016).
Cited by
Sorted by citations
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martínez-Colón, G. J., McKechnie, J. L., Ivison, G. T., Ranganath, T., Vergara, R., Hollis, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0944-y · Cited by 1,493
Self-citationImmunological considerations for COVID-19 vaccine strategies
Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00434-6 · Cited by 1,015
The immunology and immunopathology of COVID-19
Mérad, M., Blish, C. A., Sallusto, F., & Iwasaki, A. (2022) · Science · doi:10.1126/science.abm8108 · Cited by 780
Self-citationFcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Junqueira, C., Crespo, Â. C., Ranjbar, S., de Lacerda, L., Lewandrowski, M., Ingber, J., Parry, B. A., Ravid, S., Clark, S. A., Schrimpf, M. R., et al. (2022) · Nature · doi:10.1038/s41586-022-04702-4 · Cited by 699
Pathological sequelae of long-haul COVID
Mehandru, S., & Mérad, M. (2022) · Nature Immunology · doi:10.1038/s41590-021-01104-y · Cited by 675
Metadata
- Authors
- Chakraborty, S., Gonzalez, J., Edwards, K., Mallajosyula, V., Buzzanco, A. S., Sherwood, R., Buffone, C., Kathale, N., Providenza, S., Xie, M. M., Andrews, J. R., Blish, C. A., Singh, U., Dugan, H., Wilson, P. C., Pham, T. D., Boyd, S. D., Nadeau, K. C., Pinsky, B. A., Zhang, S., Memoli, M. J., Taubenberger, J. K., Morales, T., Schapiro, J. M., Tan, G. S., Jagannathan, P., & Wang, T. T.
- Affiliations
- Stanford Medicine (US)
- Stanford University (US)
- Cornell University (US)
- Chan Zuckerberg Biohub San Francisco (US)
- University of Chicago (US)
- Stanford Blood Center (US)
- National Institutes of Health (US)
- Kaiser Permanente Northern California (US)
- J. Craig Venter Institute (US)
- Corresponding author
- Wang, Taia T.
- ORCID
- Chakraborty, Saborni
- Edwards, Karlie
- Mallajosyula, Vamsee
- Buzzanco, Anthony S.
- Buffone, Cindy
- Xie, Markus M.
- Andrews, Jason R.
- Blish, Catherine A.
- Singh, Upinder
- Dugan, Haley
- Wilson, Patrick C.
- Pham, Tho D.
- Boyd, Scott D.
- Nadeau, Kari C.
- Pinsky, Benjamin A.
- Zhang, Sheng
- Memoli, Matthew J.
- Taubenberger, Jeffery K.
- Tan, Gene S.
- Jagannathan, Prasanna
- Wang, Taia T.
- Venue
- Nature Immunology
- Published
- 2020-11-09
- Volume
- 22
- Issue
- 1
- Pages
- 67-73
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC8130642
- OpenAlex
- W3105885548
- Cited by
- 326
- References
- 41
- Citations by year
- 2026: 25 · 2025: 35 · 2024: 32 · 2023: 41 · 2022: 98 · 2021: 83 · 2020: 12
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature Immunology (publishedVersion)
- medRxiv (acceptedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, cc-by)
- PubMed Central (acceptedVersion)
- PubMed Central (submittedVersion)
- ImmPort
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI139119, U54CA260517, U19AI111825)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- severe COVID-19, SARS-CoV-2, IgG1, Fc glycan, afucosylation, FcγRIIIa, Fcγ receptor binding, immune complexes, monocytes, interleukin-6, TNF-α, hyperinflammation, disease severity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
